hat
nan “DataSmart” platfòm pral pèmèt biotechnologie ak pharmaceutique konpayi yo demontre sinsérité la nan elektwonikman soumèt done rechèch ki nan regilatè – espesyalman sa ki konpayi jwenn pandan premye etap yo préclinique ak klinik nan devlopman dwòg.
eng
The “DataSmart” platform will allow biotechnology and pharmaceutical companies to demonstrate the veracity of electronically submitted research data to regulators – specifically that which companies obtain during the preclinical and clinical stages of drug development.